Current position:Home >Product >
2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, compd. with N-cyclohexylcyclohexanamine (1:1)
2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, compd. with N-cyclohexylcyclohexanamine (1:1)(1137606-74-6)
- Name: 2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, compd. with N-cyclohexylcyclohexanamine (1:1)
- Synonyms:2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, coMpd. with N-cyclohexylcyclohexanaMine (1:1)
- Molecular Formula:C12H23N.C5H2FN3O
- Molecular Weight:320.41
- CAS Registry Number:1137606-74-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 530141-72-1/Benzenepropanoic acid, 5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2,3-dihydro-3-oxo-1,2-benzisoxazol-6-yl)methoxy]-
- 871484-32-1/Benzenebutanamide, 4-[[3-[(4-deoxy-4-fluoro-β-D-glucopyranosyl)oxy]-5-(1-methylethyl)-1H-pyrazol-4-yl]methyl]-N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]-
- 165172-60-1/Thymidine, 2',3'-didehydro-3'-deoxy-, compd. with 1-methyl-2-pyrrolidinone (1:1) (9CI)
- 220099-91-2/Spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine], (2'R)-
- 220100-81-2/Spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine], (2'R)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1) (9CI)
- 163680-80-6/7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 10-[1-(acetylamino)cyclopropyl]-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (S)- (9CI)
- 690270-65-6/Cytidine, 4'-C-azido-, 2',3',5'-tris(2-methylpropanoate), hydrochloride (1:1)
- 812647-80-6/Uridine, 4'-C-azido-, 2',3'-dibenzoate 5'-(3-chlorobenzoate) (9CI)
- 914361-45-8/L-Lysine, compd. with 4-[2-[(1R,2R)-2-(2,4-difluorophenyl)-1-methyl-2-[(phosphonooxy)methoxy]-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile and ethanol (1:1:1) (9CI)
- 866920-24-3/1,2,4-Oxadiazol-5(2H)-one, 3-[2-chloro-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methoxy]phenyl]-
- 127660-04-2/4-Thiazoleacetic acid, 2-amino-α-(hydroxyimino)-, monosodium salt, (αZ)- (9CI)
- 1137606-74-6/2-Pyrazinecarbonitrile, 6-fluoro-3,4-dihydro-3-oxo-, compd. with N-cyclohexylcyclohexanamine (1:1)
- 912445-36-4/1H-Benzimidazole-7-carboxamide, 2-[(2S)-2-methyl-2-pyrrolidinyl]-, hydrochloride (1:2)
- 952490-01-6/Propanoic acid, 2,2-dimethyl-, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl ester
- 1000164-36-2/Alanine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-glutaminyl-L-alanyl-L-alanyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-1-[(1,1-dimethylethoxy)carbonyl]-L-tryptophyl-L-leucyl-L-valyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-2-methyl-, 5-(1,1-dimethylethyl) ester
- 941685-39-8/1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-
- 540737-29-9/Tofacitinib citrate
- 475578-12-2/1,3-Bis(2-methylphenyl)-1H-imidazolium chloride
- 475578-18-8/4,5-Dihydro-1,3-bis(2-methylphenyl)-1H-imidazolium chloride
- 1032066-96-8/6H-Purin-6-one, 2-amino-9-[(1S,3R,4S)-4-(dimethylphenylsilyl)-2-methylene-3-[(phenylmethoxy)methyl]cyclopentyl]-1,9-dihydro-, methanesulfonate (2:1)
- 134388-95-7/2,3(1H)-Isoquinolinedicarboxylic acid, octahydro-6-oxo-, 2-methyl ester, [3S-(3α,4aα,8aα)]-, compd. with (R)-α-methylbenzenemethanamine (1:1) (9CI)
- 451487-18-6/4H-Cyclopentapyrimidin-4-one, 2-[[(4-fluorophenyl)methyl]thio]-1,5,6,7-tetrahydro- (9CI)
- 868210-14-4/Butanoic acid, 4-[4-[[(2S,4R)-4-[acetyl(4-chlorophenyl)amino]-3,4-dihydro-2-methyl-1(2H)-quinolinyl]carbonyl]phenoxy]-2,2-dimethyl-
- 813452-14-1/2-Pyrrolidinone, 1-[(2S,3S,11bS)-2-amino-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizin-3-yl]-4-(fluoromethyl)-, hydrochloride (1:2), (4S)-
- 259793-88-9/6-bromo-3-hydroxypyrazine-2-carboxamide
- 1012065-72-3/Butanedioic acid, 2,3-bis(benzoyloxy)-, (2S,3S)-, compd. with ethyl (11bS)-2-amino-1,6,7,11b-tetrahydro-9,10-dimethoxy-4H-benzo[a]quinolizine-3-carboxylate (1:1)
- 936359-25-0/Benzoic acid, 2-[(3R)-3-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[[[1-(hydroxymethyl)cyclopropyl]methyl]thio]propyl]-, methyl ester
- 630100-90-2/1-Piperazinecarboxylic acid, 4-cycloheptyl-, (2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-2-[(1E,3E,5R)-5-hydroxy-6-[(2R,3R)-3-[(1R,2S)-2-hydroxy-1-methylbutyl]-2-oxiranyl]-1,5-dimethyl-1,3-hexadien-1-yl]-3,7-dimethyl-12-oxooxacyclododec-4-en-6-yl ester
- 519187-97-4/3-Azetidinol, 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-, (2Z)-2-butenedioate (1:1)
- 710281-33-7/Benzoic acid, 2-[[[(1R,3S)-3-[[2-(3-methoxyphenyl)-5-methyl-4-oxazolyl]methoxy]cyclohexyl]oxy]methyl]-6-methyl-